Insights into established and emerging roles of SR protein family in plants and animals
Splicing of pre‐mRNA is an essential part of eukaryotic gene expression. Serine‐/arginine‐
rich (SR) proteins are highly conserved RNA‐binding proteins present in all metazoans and …
rich (SR) proteins are highly conserved RNA‐binding proteins present in all metazoans and …
[HTML][HTML] Oncogenic SRSF3 in health and diseases
R Jia, ZM Zheng - International Journal of Biological Sciences, 2023 - ncbi.nlm.nih.gov
Serine/arginine rich splicing factor 3 (SRSF3) is an important multi-functional splicing factor,
and has attracted increasing attentions in the past thirty years. The importance of SRSF3 is …
and has attracted increasing attentions in the past thirty years. The importance of SRSF3 is …
Biological function and molecular mechanism of SRSF3 in cancer and beyond
J Xiong, Y Chen, W Wang, J Sun - Oncology Letters, 2022 - spandidos-publications.com
Serine/arginine‑rich splicing factor 3 (SRSF3; also known as SRp20), an important member
of the family of SRSFs, is abnormally expressed in tumors, resulting in aberrant splicing of …
of the family of SRSFs, is abnormally expressed in tumors, resulting in aberrant splicing of …
The role of RNA-binding proteins in vertebrate neural crest and craniofacial development
TE Forman, BJC Dennison, KA Fantauzzo - Journal of developmental …, 2021 - mdpi.com
Cranial neural crest (NC) cells delaminate from the neural folds in the forebrain to the
hindbrain during mammalian embryogenesis and migrate into the frontonasal prominence …
hindbrain during mammalian embryogenesis and migrate into the frontonasal prominence …
Functional analysis of ESRP1/2 gene variants and CTNND1 isoforms in orofacial cleft pathogenesis
C Caetano da Silva, C Macias Trevino… - Communications …, 2024 - nature.com
Orofacial cleft (OFC) is a common human congenital anomaly. Epithelial-specific RNA
splicing regulators ESRP1 and ESRP2 regulate craniofacial morphogenesis and their …
splicing regulators ESRP1 and ESRP2 regulate craniofacial morphogenesis and their …
TXNL4B regulates radioresistance by controlling the PRP3‐mediated alternative splicing of FANCI
Z Ju, J Xiang, L Xiao, Y He, L Zhang, Y Wang… - MedComm, 2023 - Wiley Online Library
Ionizing radiation (IR) has been extensively used for cancer therapy, but the radioresistance
hinders and undermines the radiotherapy efficacy in clinics greatly. Here, we reported that …
hinders and undermines the radiotherapy efficacy in clinics greatly. Here, we reported that …
The oncogenic PI3K-induced transcriptomic landscape reveals key functions in splicing and gene expression regulation
Abstract The phosphoinositide 3–kinase (PI3K) pathway regulates proliferation, survival,
and metabolism and is frequently activated across human cancers. A comprehensive …
and metabolism and is frequently activated across human cancers. A comprehensive …
RNA-binding protein Elavl1/HuR is required for maintenance of cranial neural crest specification
While neural crest development is known to be transcriptionally controlled via sequential
activation of gene regulatory networks (GRNs), recent evidence increasingly implicates a …
activation of gene regulatory networks (GRNs), recent evidence increasingly implicates a …
[HTML][HTML] PDGFRα signaling regulates Srsf3 transcript binding to affect PI3K signaling and endosomal trafficking
Signaling through the platelet-derived growth factor receptor alpha (PDGFRa) plays a critical
role in craniofacial development, as mutations in PDGFRA are associated with cleft …
role in craniofacial development, as mutations in PDGFRA are associated with cleft …
[HTML][HTML] PDGFRα/β heterodimer activation negatively affects downstream ERK1/2 signaling and cellular proliferation
MB Campaña, MR Perkins, MC McCabe, A Neumann… - bioRxiv, 2023 - ncbi.nlm.nih.gov
The platelet-derived growth factor receptor (PDGFR) family of receptor tyrosine kinases
allows cells to communicate with one another by binding to growth factors at the plasma …
allows cells to communicate with one another by binding to growth factors at the plasma …